Bristol Halts Development Of Vinflunine In Bladder Cancer
Company is in discussions with FDA regarding novel cytotoxic, but does not expect to file an NDA for bladder cancer; vinflunine program also includes lung and breast cancer studies.
Company is in discussions with FDA regarding novel cytotoxic, but does not expect to file an NDA for bladder cancer; vinflunine program also includes lung and breast cancer studies.